Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial
Titel:
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial
Auteur:
Deodhar, Atul Helliwell, Philip S Boehncke, Wolf-Henning Kollmeier, Alexa P Hsia, Elizabeth C Subramanian, Ramanand A Xu, Xie L Sheng, Shihong Agarwal, Prasheen Zhou, Bei Zhuang, Yanli Ritchlin, Christopher T